Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda in advanced sarcomas
NCT02301039Phase 2Completed
- Sponsor
- Sarcoma Alliance for Research through Collaboration
- Start
- Mar 2015
- Primary completion
- Jul 2020
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in soft tissue sarcoma (STS), bone sarcoma, sponsored by Sarcoma Alliance for Research through Collaboration. Started Mar 2015; status: completed.
02
Drugs
03
Conditions
soft tissue sarcoma (STS)bone sarcoma
Beyond the preview
Go deeper on NCT02301039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02301039.